Jinyu Bio-Technology Co Ltd
SSE:600201
Jinyu Bio-Technology Co Ltd
Change in Working Capital
Jinyu Bio-Technology Co Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
J
|
Jinyu Bio-Technology Co Ltd
SSE:600201
|
Change in Working Capital
-ÂĄ652.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Change in Working Capital
-ÂĄ12.8B
|
CAGR 3-Years
-278%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
||
Innovent Biologics Inc
HKEX:1801
|
Change in Working Capital
ÂĄ558m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Change in Working Capital
-ÂĄ3.9B
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
||
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Change in Working Capital
-ÂĄ3.9B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-32%
|
||
Imeik Technology Development Co Ltd
SZSE:300896
|
Change in Working Capital
-ÂĄ496.4m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
Jinyu Bio-Technology Co Ltd
Glance View
Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.
See Also
What is Jinyu Bio-Technology Co Ltd's Change in Working Capital?
Change in Working Capital
-652.8m
CNY
Based on the financial report for Sep 30, 2024, Jinyu Bio-Technology Co Ltd's Change in Working Capital amounts to -652.8m CNY.
What is Jinyu Bio-Technology Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-6%
Over the last year, the Change in Working Capital growth was -28%. The average annual Change in Working Capital growth rates for Jinyu Bio-Technology Co Ltd have been -14% over the past three years , -6% over the past five years .